These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10369817)

  • 21. Evaluation of the Braak staging of brain pathology with
    Cao H; Shi J; Cao B; Kang B; Zhang M; Qu Q
    Neurosci Lett; 2017 Nov; 660():57-62. PubMed ID: 28844732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brainstem 1H-MR spectroscopy in patients with Parkinson's disease with REM sleep behavior disorder and IPD patients without dream enactment behavior.
    Hanoglu L; Ozer F; Meral H; Dincer A
    Clin Neurol Neurosurg; 2006 Feb; 108(2):129-34. PubMed ID: 15936138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalamic neurometabolic alterations in tremulous Parkinson's disease: A preliminary proton MR spectroscopy study.
    Barbagallo G; Arabia G; Morelli M; Nisticò R; Novellino F; Salsone M; Rocca F; Quattrone A; Caracciolo M; Sabatini U; Cherubini A; Quattrone A
    Parkinsonism Relat Disord; 2017 Oct; 43():78-84. PubMed ID: 28774469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
    Appenzeller S; Li LM; Costallat LT; Cendes F
    Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.
    Federico F; Simone IL; Lucivero V; Iliceto G; De Mari M; Giannini P; Mezzapesa DM; Tarantino A; Lamberti P
    Mov Disord; 1997 Nov; 12(6):903-9. PubMed ID: 9399213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
    Targosz-Gajniak MG; Siuda JS; Wicher MM; Banasik TJ; Bujak MA; Augusciak-Duma AM; Opala G
    J Neurol Sci; 2013 Dec; 335(1-2):58-63. PubMed ID: 24035276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy.
    Federico F; Simone IL; Lucivero V; De Mari M; Giannini P; Iliceto G; Mezzapesa DM; Lamberti P
    J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):239-42. PubMed ID: 9069478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
    Fayed N; Dávila J; Oliveros A; Medrano J; Castillo J
    Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease.
    Pagonabarraga J; Gómez-Ansón B; Rotger R; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A; Delfino M; Ruscalleda J; Kulisevsky J
    Dement Geriatr Cogn Disord; 2012; 34(5-6):312-8. PubMed ID: 23208306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
    Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton MR spectroscopic imaging of the striatum in Parkinson's disease.
    Cruz CJ; Aminoff MJ; Meyerhoff DJ; Graham SH; Weiner MW
    Magn Reson Imaging; 1997; 15(6):619-24. PubMed ID: 9285801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment.
    Nie K; Zhang Y; Huang B; Wang L; Zhao J; Huang Z; Gan R; Wang L
    Parkinsonism Relat Disord; 2013 Mar; 19(3):329-34. PubMed ID: 23238068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cerebral metabolism in patients with cognitive disorders: a combined MRS and PET study].
    Khomenko YG; Kataeva GV; Bogdan AA; Chernysheva EM; Susin DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(1):51-58. PubMed ID: 30778031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases.
    Hoang TQ; Bluml S; Dubowitz DJ; Moats R; Kopyov O; Jacques D; Ross BD
    Neurology; 1998 Apr; 50(4):1033-40. PubMed ID: 9566391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered white and gray matter metabolism in CADASIL: a proton MR spectroscopy and 1H-MRSI study.
    Auer DP; Schirmer T; Heidenreich JO; Herzog J; Pütz B; Dichgans M
    Neurology; 2001 Mar; 56(5):635-42. PubMed ID: 11245716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton Magnetic Resonance Spectroscopy for Diagnosis of Non-Motor Symptoms in Parkinson's Disease.
    Guan JT; Zheng X; Lai L; Sun S; Geng Y; Zhang X; Zhou T; Wu HZ; Chen JQ; Yang ZX; Zheng XH; Wang JX; Chen W; Zhang YQ
    Front Neurol; 2022; 13():594711. PubMed ID: 35295827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study.
    Holshouser BA; Komu M; Möller HE; Zijlmans J; Kolem H; Hinshaw DB; Sonninen P; Vermathen P; Heerschap A; Masur H
    Magn Reson Med; 1995 May; 33(5):589-94. PubMed ID: 7596261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of mitochondrial impairment in traumatic brain injury using high-resolution proton magnetic resonance spectroscopy.
    Signoretti S; Marmarou A; Aygok GA; Fatouros PP; Portella G; Bullock RM
    J Neurosurg; 2008 Jan; 108(1):42-52. PubMed ID: 18173309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRS study on lentiform nucleus in idiopathic Parkinson's disease with unilateral symptoms.
    Zheng XN; Zhu XC; Ruan LX; Zhang LJ; Yuan M; Shang DS; Liu Y
    J Zhejiang Univ Sci; 2004 Feb; 5(2):246-50. PubMed ID: 14674041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.